Risk factors and survival of patients infected with carbapenem-resistant Klebsiella pneumoniae in a KPC endemic setting: a case-control and cohort study - Cienfuegos-Gallet, Astrid V.; Ocampo de Los Ríos, Ana M.; Sierra Viana, Patricia; Ramirez Brinez, Faiver; Restrepo Castro, Carlos; Roncancio Villamil, Gustavo; del Corral Londoño, Helena; Jiménez, J. Natalia (BMC infectious diseases, 2019)
Keywords: Aged; Anti-Bacterial Agents - adverse effects; Anti-Bacterial Agents - therapeutic use; Antibiotic resistance; Antibiotics; Bacterial and fungal diseases; Carbapenem resistance; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Case-Control Studies; Case-control study; Cefepime; Cefepime - adverse effects; Cefepime - therapeutic use; Ciprofloxacin; Ciprofloxacin - adverse effects; Ciprofloxacin - therapeutic use; Cohort analysis; Cohort study; Colombia; Control methods; Drug resistance; Drug Resistance, Multiple, Bacterial; Drug therapy; Endemic Diseases; Epidemiology; Factor analysis; Failure analysis; Failure times; Female; Genotype; Hospitals; Humans; Infections; Infectious Diseases; innapropriate therapy; Internal Medicine; Kaplan-Meier Estimate; Klebsiella; Klebsiella Infections - drug therapy; Klebsiella Infections - mortality; Klebsiella pneumoniae; Klebsiella pneumoniae - genetics; Klebsiella pneumoniae - isolation & purification; Laboratories; length of antibiotic use; Logistic Models; Male; Medical equipment; Medical instruments; Medical Microbiology; Medical research; Medicine; Medicine & Public Health; Meropenem; Meropenem - adverse effects; Meropenem - therapeutic use; Microbial drug resistance; Middle Aged; Mortality; Parasitology; Pathogenic microorganisms; Patient outcomes; Patients; Phenotype; Pneumonia; Population; Prospective Studies; Regression analysis; Regression models; Research Article; Resistance factors; Risk analysis; Risk Factors; Studies; Surveillance; Survival; Survival Analysis; Therapy; Tropical Medicine; Urinary Catheters - adverse effects; Colombia; risk factors; length of antibiotic use; Cohort study; innapropriate therapy; mortality; Case-control study; Carbapenem resistance; Klebsiella pneumoniae